These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


185 related items for PubMed ID: 20081198

  • 1. Structure of the DNA-bound BRCA1 C-terminal region from human replication factor C p140 and model of the protein-DNA complex.
    Kobayashi M, Ab E, Bonvin AMJJ, Siegal G.
    J Biol Chem; 2010 Mar 26; 285(13):10087-10097. PubMed ID: 20081198
    [Abstract] [Full Text] [Related]

  • 2. Characterization of the DNA binding and structural properties of the BRCT region of human replication factor C p140 subunit.
    Kobayashi M, Figaroa F, Meeuwenoord N, Jansen LE, Siegal G.
    J Biol Chem; 2006 Feb 17; 281(7):4308-17. PubMed ID: 16361700
    [Abstract] [Full Text] [Related]

  • 3. Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains.
    Rodriguez M, Yu X, Chen J, Songyang Z.
    J Biol Chem; 2003 Dec 26; 278(52):52914-8. PubMed ID: 14578343
    [Abstract] [Full Text] [Related]

  • 4. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins.
    Bork P, Hofmann K, Bucher P, Neuwald AF, Altschul SF, Koonin EV.
    FASEB J; 1997 Jan 26; 11(1):68-76. PubMed ID: 9034168
    [Abstract] [Full Text] [Related]

  • 5. Structural basis of BACH1 phosphopeptide recognition by BRCA1 tandem BRCT domains.
    Botuyan MV, Nominé Y, Yu X, Juranic N, Macura S, Chen J, Mer G.
    Structure; 2004 Jul 26; 12(7):1137-46. PubMed ID: 15242590
    [Abstract] [Full Text] [Related]

  • 6. NMR mapping of PCNA interaction with translesion synthesis DNA polymerase Rev1 mediated by Rev1-BRCT domain.
    Pustovalova Y, Maciejewski MW, Korzhnev DM.
    J Mol Biol; 2013 Sep 09; 425(17):3091-105. PubMed ID: 23747975
    [Abstract] [Full Text] [Related]

  • 7. Solution structure, backbone dynamics, and association behavior of the C-terminal BRCT domain from the breast cancer-associated protein BRCA1.
    Gaiser OJ, Ball LJ, Schmieder P, Leitner D, Strauss H, Wahl M, Kühne R, Oschkinat H, Heinemann U.
    Biochemistry; 2004 Dec 28; 43(51):15983-95. PubMed ID: 15609993
    [Abstract] [Full Text] [Related]

  • 8. Solution structure and backbone dynamics of the human DNA ligase IIIalpha BRCT domain.
    Krishnan VV, Thornton KH, Thelen MP, Cosman M.
    Biochemistry; 2001 Nov 06; 40(44):13158-66. PubMed ID: 11683624
    [Abstract] [Full Text] [Related]

  • 9. Phosphopeptide interactions with BRCA1 BRCT domains: More than just a motif.
    Wu Q, Jubb H, Blundell TL.
    Prog Biophys Mol Biol; 2015 Mar 06; 117(2-3):143-148. PubMed ID: 25701377
    [Abstract] [Full Text] [Related]

  • 10. Structure of the BRCT repeats of BRCA1 bound to a BACH1 phosphopeptide: implications for signaling.
    Shiozaki EN, Gu L, Yan N, Shi Y.
    Mol Cell; 2004 May 07; 14(3):405-12. PubMed ID: 15125843
    [Abstract] [Full Text] [Related]

  • 11. Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure.
    Joo WS, Jeffrey PD, Cantor SB, Finnin MS, Livingston DM, Pavletich NP.
    Genes Dev; 2002 Mar 01; 16(5):583-93. PubMed ID: 11877378
    [Abstract] [Full Text] [Related]

  • 12. The BRCA1 C-terminal domain: structure and function.
    Huyton T, Bates PA, Zhang X, Sternberg MJ, Freemont PS.
    Mutat Res; 2000 Aug 30; 460(3-4):319-32. PubMed ID: 10946236
    [Abstract] [Full Text] [Related]

  • 13. Kinetic analysis of interaction of BRCA1 tandem breast cancer c-terminal domains with phosphorylated peptides reveals two binding conformations.
    Nominé Y, Botuyan MV, Bajzer Z, Owen WG, Caride AJ, Wasielewski E, Mer G.
    Biochemistry; 2008 Sep 16; 47(37):9866-79. PubMed ID: 18717574
    [Abstract] [Full Text] [Related]

  • 14. A Dbf4p BRCA1 C-terminal-like domain required for the response to replication fork arrest in budding yeast.
    Gabrielse C, Miller CT, McConnell KH, DeWard A, Fox CA, Weinreich M.
    Genetics; 2006 Jun 16; 173(2):541-55. PubMed ID: 16547092
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of deletion and site-directed mutations on ligation steps of NAD+-dependent DNA ligase: a biochemical analysis of BRCA1 C-terminal domain.
    Feng H, Parker JM, Lu J, Cao W.
    Biochemistry; 2004 Oct 05; 43(39):12648-59. PubMed ID: 15449954
    [Abstract] [Full Text] [Related]

  • 19. The BRCT domain is a phospho-protein binding domain.
    Yu X, Chini CC, He M, Mer G, Chen J.
    Science; 2003 Oct 24; 302(5645):639-42. PubMed ID: 14576433
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.